Table of Contents
International Journal of Molecular Imaging
Volume 2011 (2011), Article ID 828151, 7 pages
http://dx.doi.org/10.1155/2011/828151
Research Article

Immunolymphoscintigraphy for Metastatic Sentinel Nodes: Test of a Model

1Clinic of Plastic Surgery, Breast Surgery and Burns Unit, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
2The Finsen Laboratory, Rigshospitalet, 2100 Copenhagen, Denmark
3Diagnostic Product Development Division, Exiqon A/S, 2950 Vedbaek, Denmark
4Clinic of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, 2950 Copenhagen, Denmark
5Novo Nordisk A/S, 2880 Bagsvaerd, Denmark
6Institute of Molecular Pathology, University of Copenhagen, 1165 Copenhagen, Denmark
7Faculty of Medical Laboratory Science, Metropolitan University College, 1150 Copenhagen, Denmark
8Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, 1165 Copenhagen, Denmark
9Department of Surgery, Lunds University Hospital, 221 85 Lund, Sweden
10Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, 1165 Copenhagen, Denmark

Received 30 November 2010; Accepted 1 March 2011

Academic Editor: Francesca Pons

Copyright © 2011 A. H. Chakera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Veronesi, A. Luini, V. Galimberti, S. Marchini, V. Sacchini, and F. Rilke, “Extent of metastatic axillary involvement in 1446 cases of breast cancer,” European Journal of Surgical Oncology, vol. 16, no. 2, pp. 127–133, 1990. View at Google Scholar · View at Scopus
  2. U. Veronesi, J. Adamus, and D. C. Bandiera, “Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities,” Cancer, vol. 49, no. 11, pp. 2420–2430, 1982. View at Google Scholar · View at Scopus
  3. N. Cascinelli, A. Morabito, M. Santinami, R. M. Mackie, and F. Belli, “Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme,” Lancet, vol. 351, no. 9105, pp. 793–796, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. D. L. Morton, D. R. Wen, J. H. Wong et al., “Technical details of intraoperative lymphatic mapping for early stage melanoma,” Archives of Surgery, vol. 127, no. 4, pp. 392–399, 1992. View at Google Scholar · View at Scopus
  5. D. M. Goldenberg, J. F. Chatal, J. Barbet, O. Boerman, and R. M. Sharkey, “Cancer imaging and therapy with bispecific antibody pretargeting,” Update on Cancer Therapeutics, vol. 2, no. 1, pp. 19–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. A. Harrison and M. A. Tempero, “Diagnostic use of radiolabeled antibodies for cancer,” Oncology, vol. 9, no. 7, pp. 625–631, 1995. View at Google Scholar · View at Scopus
  7. L. Biassoni, M. Granowska, M. J. Carroll et al., “99m Tc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection,” British Journal of Cancer, vol. 77, no. 1, pp. 131–138, 1998. View at Google Scholar · View at Scopus
  8. A. R. Al-Yasi, M. J. Carroll, D. Ellison et al., “Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFGI,” British Journal of Cancer, vol. 86, no. 6, pp. 870–878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Wahl, M. Liebert, B. S. Wilson, and N. A. Petry, “Radiolabeled antibodies, albumin and antimony sulfide colloid: a comparison as lymphoscintigraphic agents,” Nuclear Medicine and Biology, vol. 15, no. 3, pp. 243–250, 1988. View at Google Scholar · View at Scopus
  10. C. Ingvar, K. Norrgren, S. E. Strand, T. Brodin, P. E. Jonsson, and H. O. Sjogren, “Tumour uptake of monoclonal antibody after regional intraarterial injection. Biokinetics in the nude rat heterotransplanted with malignant melanoma,” Acta Oncologica, vol. 30, no. 1, pp. 65–69, 1991. View at Google Scholar · View at Scopus
  11. M. Bartolomei, A. Testori, M. Chinol et al., “Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping,” European Journal of Nuclear Medicine, vol. 25, no. 11, pp. 1489–1494, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. R. L. Wahl, M. Liebert, J. Headington et al., “Lymphoscintigraphy in melanoma: initial evaluation of a low protein dose monoclonal antibody cocktail,” Cancer Research, vol. 50, no. 3, supplement, pp. 941s–948s, 1990. View at Google Scholar · View at Scopus
  13. L. M. Fig, R. S. Brown, L. Von Moll et al., “Immunolymphoscintigraphy in breast cancer: evaluation using I- labeled monoclonal antibody B72.3,” Nuclear Medicine and Biology, vol. 25, no. 3, pp. 251–260, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Shulman, C. D. Wilde, and G. Kohler, “A better cell line for making hybridomas secreting specific antibodies,” Nature, vol. 276, no. 5685, pp. 269–270, 1978. View at Google Scholar · View at Scopus
  15. T. M. Behr, M. Gotthardt, W. Becker, and M. Béhé, “Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy: a review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience,” Nuklearmedizin, vol. 41, no. 2, pp. 71–79, 2002. View at Google Scholar · View at Scopus
  16. P. J. Early and D. B. Sodee, “New approaches to radiolabeling monoclonal antibodies,” in Principles and Practice of Nuclear Medicine, pp. 511–515, Mosby, St. Louis, Mo, USA, 2nd edition, 1995. View at Google Scholar
  17. J. N. Weinstein, “Antibody lymphoscintigraphy,” Cancer Treatment and Research, vol. 51, pp. 365–385, 1990. View at Google Scholar · View at Scopus
  18. A. J. Wilhelm, G. S. Mijnhout, and E. J. F. Franssen, “Radiopharmaceuticals in sentinel lymph-node detection—an overview,” European Journal of Nuclear Medicine, vol. 26, pp. S36–S42, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Canavese, M. Gipponi, A. Catturich et al., “Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients,” Journal of Surgical Oncology, vol. 74, no. 1, pp. 69–74, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Suami, W. R. Pan, G. B. Mann, and G. I. Taylor, “The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study,” Annals of Surgical Oncology, vol. 15, no. 3, pp. 863–871, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. O. A. Gansow, “Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates,” Nuclear Medicine and Biology, vol. 18, no. 4, pp. 369–381, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. G. R. Mirick, B. M. Bradt, S. J. Denardo, and G. L. Denardo, “A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies not four letter words,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 4, pp. 251–257, 2004. View at Google Scholar · View at Scopus